MIMalik Faisal Iftekhar

Malik Faisal Iftekhar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Malik Faisal Iftekhar has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Editorial Comment: Khat Use and Acute Myocardial Infarction: Does the Timing of Symptom Onset Matter?

    by Malik Faisal Iftekhar

    Acute myocardial infarction (AMI) exhibits distinct circadian variations, reflecting the complex interplay between autonomic nervous system activity, vascular tone, platelet reactivity, hormonal fluctuations, and myocardial oxygen demand. These physiological processes contribute to temporal variations in the occurrence of acute coronary events. In populations where khat chewing is culturally prevalent, exposure to cathinone, the principal psychoactive constituent of khat, introduces an additional consideration in understanding cardiovascular risk. The study by Al-Zakari and colleagues, published in the Pakistan Heart Journal, explores this relationship by examining whether the timing of AMI symptom onset among habitual khat chewers is associated with differences in clinical presentation and in-hospital outcomes [1]. In this prospective observational study, 200 patients presenting with AMI at a tertiary cardiac center in Sana’a, Yemen, were evaluated according to the timing of symptom onset. Participants were categorized into a khat-effective period (15:00–00:00) and a khat-inactive period (00:01–14:59). Although a greater proportion of patients experienced symptom onset during the khat-effective period (54.5%) than during the inactive period (45.5%), the reported difference was not statistically significant (p=0.203). However, patients experiencing symptom onset during the khat-effective period demonstrated significantly higher frequencies of acute heart failure and cardiogenic shock. These findings raise important questions regarding the potential interaction between stimulant exposure, circadian cardiovascular physiology, and the severity of acute coronary events. Biological Plausibility and Challenges in Establishing Causality: Khat contains cathinone, a naturally occurring sympathomimetic alkaloid capable of stimulating adrenergic pathways, increasing heart rate and blood pressure, and potentially promoting coronary vasoconstriction. These effects may increase myocardial oxygen demand while compromising coronary oxygen supply, particularly in individuals with underlying cardiovascular disease. Previous investigations have identified associations between khat consumption and adverse cardiovascular outcomes, including acute coronary syndromes and myocardial infarction [2,3]. Additional evidence has linked khat chewing with unfavorable outcomes among patients presenting with acute coronary syndromes [4], while broader reviews have highlighted its systemic health implications [5]. Nevertheless, the biological plausibility of these mechanisms should not be interpreted as confirmation of a causal relationship in the present study. Because all enrolled participants were habitual khat chewers, the absence of a non-chewing comparison group limits the ability to determine whether khat consumption independently increases AMI risk or alters its circadian distribution. Furthermore, the statistically nonsignificant difference in symptom-onset frequency between the predefined periods does not support a definitive conclusion that AMI occurs more frequently during presumed periods of khat activity. An additional methodological concern is the use of predefined clock-time intervals as indirect indicators of pharmacological exposure. The cardiovascular effects of khat are influenced by several factors, including the quantity consumed, duration of chewing, frequency of use, individual metabolic differences, and the interval between consumption and symptom onset. Consequently, assigning patients to khat-effective or khat-inactive periods solely on the basis of symptom-onset time may introduce exposure misclassification. The potential influence of endogenous circadian rhythms must also be considered. Cardiovascular vulnerability fluctuates across the 24-hour cycle because of changes in sympathetic activity, blood pressure, vascular responsiveness, and hemostatic function. These variations may contribute independently to temporal patterns of acute coronary events [6]. Without detailed individual exposure histories and appropriate adjustment for circadian influences, distinguishing the effects of khat consumption from underlying biological rhythms remains challenging. Clinical Significance of Adverse In-Hospital Outcomes: One of the most clinically relevant observations reported by Al-Zakari and colleagues is the higher frequency of acute heart failure (14.7% versus 5.5%; p=0.035) and cardiogenic shock (12.8% versus 2.2%; p=0.006) among patients whose symptoms began during the khat-effective period [1]. These findings warrant particular attention because both complications are associated with substantial morbidity and may reflect greater hemodynamic instability during the acute phase of myocardial infarction. A possible explanation involves the sympathomimetic effects of cathinone, which may intensify myocardial workload, alter coronary vascular resistance, and exacerbate ischemic injury in susceptible individuals. However, these mechanisms remain hypothetical in relation to the observed outcome differences and cannot be established from the available observational findings. The relatively modest sample size and limited number of complication events further restrict the precision and generalizability of the estimates. Importantly, identifying predictors of symptom-onset timing is not equivalent to demonstrating that timing independently predicts adverse clinical outcomes. Differences in infarct severity, infarct location, baseline ventricular function, coronary disease burden, tobacco consumption, coexisting illnesses, and delays in seeking medical attention may have contributed to the observed associations. Accordingly, future analyses should examine whether the relationship between symptom-onset period and adverse outcomes persists after adjustment for clinically relevant confounders. Effect estimates with corresponding 95% confidence intervals would also help clarify the magnitude...

  • Open Access

    Pre-Hospital Delay and Factors Associated With Delayed Presentation Among Patients With ST-Segment Elevation Myocardial Infarction in Peshawar: A Cross-Sectional Study

    by Malik Faisal Iftekhar, Mansoor Ali Yazdan Khan, Uzma Saddique

    Objectives: To determine the frequency of pre-hospital delay and identify factors independently associated with delayed presentation among patients with ST-segment elevation myocardial infarction (STEMI) presenting to a tertiary cardiac care center in Peshawar, Pakistan. Methodology: This analytical cross-sectional study included a total of 255 consecutive adults with confirmed STEMI. Data were collected using a structured, pilot-tested pro forma covering sociodemographic characteristics, symptom interpretation, healthcare-seeking behavior, first medical contact, geographic distance, and symptom-onset-to-Coronary Care Unit (CCU)-arrival time. Pre-hospital delay was operationally defined as a symptom-onset-to-CCU-arrival interval >6 hours; this composite interval could include both patient-related and healthcare-system/referral-related components. Results: The mean age of the 255 participants was 59.93 ± 10.57 years, and 133 (52.2%) were female. The median symptom-onset-to-CCU-arrival time was 5.0 hours (IQR: 2.5–9.5), and 123 (48.2%) participants presented >6 hours after symptom onset. After multivariable adjustment, increasing age was associated with greater odds of delay (aOR=1.19 per year; 95% CI: 1.12–1.27; p<0.001), whereas male gender was associated with substantially lower odds compared with female gender (aOR=0.03; 95% CI: 0.01–0.10; p<0.001). Musculoskeletal rather than gastrointestinal symptom misinterpretation (aOR=8.42; 95% CI: 2.94–24.10; p<0.001), misguided healthcare-seeking behavior (aOR=11.18; 95% CI: 4.46–28.02; p<0.001), and first medical contact with a local hospital rather than a cardiac care center (aOR=14.67; 95% CI: 5.42–39.69; p<0.001) were associated with greater odds of delayed presentation. Intermediate versus remote distance was associated with lower odds of delay (aOR=0.09; 95% CI: 0.03–0.27; p<0.001). Educational level, urban/rural residence, economic status, and proximate versus remote distance were not independently associated with delay. Conclusion: Nearly half of the patients with STEMI presented to definitive cardiac care more than six hours after symptom onset. Delayed presentation was associated with older age, female gender, musculoskeletal symptom misinterpretation, misguided healthcare-seeking behavior, and initial contact with a local non-cardiac facility.

  • Open Access

    Diagnostic Accuracy of the H2FPEF Score for Identifying Heart Failure with Preserved Ejection Fraction in Adults with Suspected HFpEF at a Tertiary Care Hospital in Pakistan

    by Malik Faisal Iftekhar, Muhammad Adil, Uzma Siddique

    Objective: To evaluate the diagnostic accuracy of the heart failure with preserved ejection fraction (HFpEF) score for identifying HFpEF in adults presenting with suspected HFpEF and to explore its association with selected in-hospital clinical outcomes. Methodology: This prospective observational diagnostic-accuracy study was conducted at Lady Reading Hospital, Peshawar, Pakistan, between January and December 2025. A total of 300 consecutive adults with symptoms suggestive of heart failure, preserved left ventricular ejection fraction (≥50%), and at least one structural or functional echocardiographic abnormality were enrolled. The H2FPEF score was calculated prospectively using predefined criteria. The reference standard diagnosis of HFpEF was established independently by a panel of three consultant cardiologists using clinical findings and echocardiographic evidence in accordance with contemporary European Society of Cardiology and HFA-PEFF recommendations. Diagnostic accuracy was evaluated using receiver operating characteristic (ROC) curve analysis, and sensitivity, specificity, predictive values, likelihood ratios, and overall accuracy were calculated at the exploratory cut-off value of ≥5. Results: Among the 300 enrolled participants, the expert panel classified 240 (80.0%) as having HFpEF and 60 (20.0%) as non-HFpEF. The H2FPEF score demonstrated good diagnostic discrimination with an area under the ROC curve (AUC) of 0.86 (95% CI: 0.82–0.90). At the exploratory cut-off value of ≥5, sensitivity was 84.2% (95% CI: 79.0–88.2), specificity 76.7% (95% CI: 64.6–85.6), positive predictive value 93.5% (95% CI: 89.4–96.1), negative predictive value 54.8% (95% CI: 44.2–65.0), and overall diagnostic accuracy 82.7% (95% CI: 78.0–86.5). Higher H2FPEF score categories were significantly associated with longer hospital stay and increased ICU admission (both p<0.001), whereas the observed increase in in-hospital mortality was not statistically significant (p=0.17). Conclusion: The H2FPEF score demonstrated good diagnostic accuracy for identifying HFpEF among adults with suspected disease in this tertiary-care cohort. The exploratory threshold of ≥5 provided a favorable balance between sensitivity and specificity; however, because the study population represented a selected high-prevalence referral cohort, external validation in broader clinical settings is warranted before routine implementation.

  • Open Access

    An integrated bioinformatics approach for identification of key modulators and biomarkers involved in atrial fibrillation

    by Summan Thahiem, Ayesha Ishtiaq, Faisal Iftekhar, Muhammad Ishtiaq Jan, Iram Murtaza

    Introduction: Atrial fibrillation (AFib) is a sustained form of cardiac arrythmia that occurs due to sympathetic overdrive, neurohumoral and electrophysiological changes. Sympatho-renal modulatory approach via miRNA-based therapeutics is likely to be an important treatment option for AFib. The study was aimed to unravel the common miRNAs as therapeutic targets involved in sympatho- renovascular axis to combat AFib. Methods: We employed the bioinformatics approach to discover differentially expressed genes (DEGs) from microarray gene expression datasets GSE41177 and GSE79768 of AFib patients. Concomitantly, genes associated with sympathetic cardio-renal axis, from Genetic Testing Registry (GTR) of National Center for Biotechnology Information (NCBI) were also analyzed. Overlapping miRNAs that target the maximum number of genes across all three pathological conditions perpetuating AFib were shortlisted. To confirm the reliability of the identified miRNAs, differential expression analysis was performed on miRNA expression profiles GSE190898, GSE68475, GSE70887 and GSE28954 derived from AFib patient samples. Results: ShinyGO analysis revealed enrichment in beta-adrenergic signaling, calcium signaling, as well as G protein-coupled receptor (GPCR) signaling involved in post synaptic membrane potential. The intersection of top 10 modules in miRNA-mRNA network revealed hub miRNAs having highest node degree, maximum neighborhood component (MNC), and maximal clique centrality (MCC) scores. Differential expression analysis revealed hub miRNAs identified through integrated approach were found to be significantly dysregulated in AFib patients. Conclusion: This integrated approach identified 6 hub miRNAs, 4 reported (miR-101-3p, miR-23-3p, miR-27-3p, miR-25-3p) and 2 novel (miR-32-5p, miR-92-3p) miRNAs that might act as putative biomarkers for AFib.